Pharmacologic effects on mitochondrial function.

Area of Science:

• Cellular Biology
• Biochemistry
• Pharmacology

Background:

• Mitochondria are central to cellular energy production, free-radical generation, and apoptosis.
• Mitochondrial structure, electrochemical properties, and dual genetic control (mtDNA, nDNA) render them susceptible to environmental and drug-induced injury.
• Mitochondrial DNA (mtDNA) translation and replication are vulnerable to specific drug classes, including antibiotics and anti-HIV medications.

Purpose of the Study:

• To explore the vulnerability of mitochondria to various drug classes.
• To elucidate the mechanisms underlying drug-induced mitochondrial dysfunction.
• To highlight the role of genetics and personalized medicine in mitigating mitochondrial drug toxicity.

Main Methods:

• Review of existing literature on drug-induced mitochondrial toxicity.
• Analysis of mechanisms involving inner mitochondrial membrane (IMM) electrochemical gradients and mtDNA replication/translation.
• Examination of genetic predispositions to drug toxicity.

Main Results:

• Numerous drug classes can induce mitochondrial dysfunction by affecting IMM electrochemical gradients, leading to free-radical generation and uncoupling of oxidative phosphorylation.
• Specific drugs targeting mtDNA replication (e.g., anti-HIV) and mtDNA translation (e.g., some antibiotics) can inhibit mitochondrial maintenance.
• Drug-induced mitochondrial toxicity can occur in healthy individuals, but genetic variations may increase susceptibility.

Conclusions:

• Mitochondrial dysfunction is a significant concern across a broad spectrum of drug classes.
• Preclinical pharmacogenetic and functional studies are essential for understanding mitochondrial drug toxicity.
• Personalized genomic medicine holds promise for improving patient safety regarding drug-induced mitochondrial damage.